TickerFacts.

A business in context

RMD research notebook

Read the disclosures. Follow the relationships. Keep the dates in view.

Research JSON

Filing timeline

Download filings CSV

SEC submissions · retrieved 2026-10-23 · 8022 issuers; up to 32 recent company reports and 8 ownership-change filings per issuer

  1. 4 · Ownership change

    Report date 2026-10-07 · 0000943819-26-000085

  2. DEF 14A · Proxy statement

    Report date 2026-06-30 · 0000943819-26-000080

  3. 4/A · Ownership change

    Report date 2026-09-08 · 0000943819-26-000078

  4. 4 · Ownership change

    Report date 2026-08-14 · 0000943819-26-000077

  5. 4 · Ownership change

    Report date 2026-08-14 · 0000943819-26-000076

  6. 4 · Ownership change

    Report date 2026-08-14 · 0000943819-26-000075

  7. 4 · Ownership change

    Report date 2026-08-14 · 0000943819-26-000073

  8. 4 · Ownership change

    Report date 2026-09-08 · 0000943819-26-000052

  9. 4 · Ownership change

    Report date 2026-09-02 · 0000943819-26-000050

  10. 8-K · Current report

    Report date 2026-08-31 · 0001193125-26-378487 · Items 8.01

  11. 8-K · Current report

    Report date 2026-08-13 · 0001193125-26-354154 · Items 4.01,5.02,7.01,9.01

  12. 10-K · Annual report

    Report date 2026-06-30 · 0000943819-26-000047

  13. 8-K · Current report

    Report date 2026-08-06 · 0001193125-26-337962 · Items 2.02,8.01,9.01

  14. 8-K · Current report

    Report date 2026-06-30 · 0001193125-26-297658 · Items 2.02,7.01,9.01

  15. 10-Q · Quarterly report

    Report date 2026-03-31 · 0000943819-26-000025

  16. 8-K · Current report

    Report date 2026-04-24 · 0001193125-26-197282 · Items 5.02,9.01

  17. 8-K · Current report

    Report date 2026-04-30 · 0001193125-26-197192 · Items 2.02,8.01,9.01

  18. 10-Q · Quarterly report

    Report date 2025-12-31 · 0000943819-26-000007

  19. 8-K · Current report

    Report date 2026-01-29 · 0001193125-26-029326 · Items 2.02,8.01,9.01

  20. 8-K · Current report

    Report date 2025-11-19 · 0001193125-25-289878 · Items 5.02,5.07,9.01

  21. 10-Q · Quarterly report

    Report date 2025-09-30 · 0000943819-25-000090

  22. 8-K · Current report

    Report date 2025-10-30 · 0001193125-25-258519 · Items 2.02,8.01,9.01

  23. DEF 14A · Proxy statement

    Report date 2025-06-30 · 0000943819-25-000079

  24. 8-K · Current report

    Report date 2025-08-15 · 0001193125-25-182695 · Items 5.02,9.01

  25. 10-K · Annual report

    Report date 2025-06-30 · 0000943819-25-000035

  26. 8-K · Current report

    Report date 2025-07-28 · 0001193125-25-170718 · Items 5.02

  27. 8-K · Current report

    Report date 2025-07-31 · 0001193125-25-170512 · Items 2.02,8.01,9.01

  28. 10-Q · Quarterly report

    Report date 2025-03-31 · 0000943819-25-000008

  29. 8-K · Current report

    Report date 2025-04-23 · 0001193125-25-091357 · Items 2.02,8.01,9.01

  30. 10-Q · Quarterly report

    Report date 2024-12-31 · 0000943819-25-000004

  31. 8-K · Current report

    Report date 2025-01-30 · 0001193125-25-017218 · Items 2.02,8.01,9.01

  32. 8-K · Current report

    Report date 2024-11-20 · 0001193125-24-263501 · Items 5.07

  33. 10-Q · Quarterly report

    Report date 2024-09-30 · 0000943819-24-000027

  34. 8-K · Current report

    Report date 2024-10-24 · 0001193125-24-242806 · Items 2.02,8.01,9.01

  35. DEF 14A · Proxy statement

    Report date 2024-06-30 · 0000943819-24-000019

  36. 8-K · Current report

    Report date 2024-08-15 · 0001193125-24-202204 · Items 5.02,9.01

  37. 10-K · Annual report

    Report date 2024-06-30 · 0000943819-24-000013

  38. 8-K · Current report

    Report date 2024-08-01 · 0001193125-24-191487 · Items 2.02,8.01,9.01

  39. 10-Q · Quarterly report

    Report date 2024-03-31 · 0000943819-24-000008

  40. 8-K · Current report

    Report date 2024-04-25 · 0001193125-24-113883 · Items 2.02,8.01,9.01

Reported insider transactions

Download transactions CSV

SEC insider transactions · retrieved 2026-10-23 · 2026 Q3: filings in this completed quarter; not a live transaction feed

Purchases and sales include open-market or private transactions. Grants, exercises and tax withholding are shown separately. Amendments and joint reports can overlap; rows are not a net-buying score. Prices retain the filing's units; consult its footnotes.

Transaction rows by code · counts, not monetary totals
Purchase: 0 transaction rows0PSale: 5 transaction rows5SGrant / award: 0 transaction rows0AExercise / conversion: 6 transaction rows6MTax / exercise payment: 0 transaction rows0FGift: 0 transaction rows0G
P · PurchaseS · SaleA · Grant / awardM · Exercise / conversionF · Tax / exercise paymentG · Gift

11 matching transaction rows.

Transaction / filedReporting ownerTypeSecuritySharesReported price
2026-09-08
2026-09-10
Farrell Michael J.
10b5-1 checkbox reported
M · Exercise / conversion
Acquired
ResMed Common Stock4991.0146.34
2026-09-08
2026-09-10
Farrell Michael J.
10b5-1 checkbox reported
S · Sale
Disposed
ResMed Common Stock4991.0222.44
2026-09-08
2026-09-10
Farrell Michael J.
10b5-1 checkbox reported
M · Exercise / conversion
Disposed
ResMed Common Stock Options
Derivative security
4991.00.0
2026-09-02
2026-09-04
FARRELL PETER C
10b5-1 checkbox reported
S · Sale
Disposed
ResMed Common Stock970.0234.73
2026-08-07
2026-08-11
Farrell Michael J.
10b5-1 checkbox reported
M · Exercise / conversion
Acquired
ResMed Common Stock4991.0146.34
2026-08-07
2026-08-11
Farrell Michael J.
10b5-1 checkbox reported
S · Sale
Disposed
ResMed Common Stock4991.0205.69
2026-08-07
2026-08-11
Farrell Michael J.
10b5-1 checkbox reported
M · Exercise / conversion
Disposed
ResMed Common Stock Options
Derivative security
4991.00.0
2026-08-05
2026-08-06
FARRELL PETER C
10b5-1 checkbox reported
S · Sale
Disposed
ResMed Common Stock8000.0225.0
2026-07-07
2026-07-09
Farrell Michael J.
10b5-1 checkbox reported
M · Exercise / conversion
Acquired
ResMed Common Stock4991.0146.34
2026-07-07
2026-07-09
Farrell Michael J.
10b5-1 checkbox reported
S · Sale
Disposed
ResMed Common Stock4991.0218.55
2026-07-07
2026-07-09
Farrell Michael J.
10b5-1 checkbox reported
M · Exercise / conversion
Disposed
ResMed Common Stock Options
Derivative security
4991.00.0

Identity & relationships

Wikidata structured data · retrieved 2026-10-23 · 1658 unambiguous CIK-linked entities; coverage is incomplete

These are sourced identity and relationship claims, with incomplete coverage. Headquarters locations do not describe sales, assets or operating exposure.

SEC issuer · 0000943819RESMED INC
ResMed (Germany)ResMed (Australia)

Showing 2 of 2 imported Wikidata subsidiary claims. Additional aliases appear below.

No parent relationship is available in this import; this is not proof of independence.

No verified LEI join available.

GLEIF legal entity reference data · retrieved 2026-10-23 · 1197 checked identities; 0 unavailable records

Search names and former names

View Wikidata identity and references ↗

  • ResMed · alias · wikidata
  • RMD · alias · wikidata
  • ResMed (Germany) · subsidiary · wikidata
  • ResMed (Australia) · subsidiary · wikidata
  • RESMED INC · subsidiary · wikidata
Explore headquarters map ↗

Revenue in constant purchasing power

USD revenue expressed in 2026-09 consumer-price dollars. Each annual period uses a CPI-U average weighted by the days in its actual reporting interval. This is a purchasing-power comparison, not a company-specific price or volume measure.

Year endedReported USD revenueCPI-adjusted USD revenue
2025-06-30$5.15B$5.46B
2024-06-30$4.69B$5.10B
2023-06-30$4.22B$4.75B
2022-06-30$3.58B$4.28B
2021-06-30$3.20B$4.09B
2020-06-30$2.96B$3.87B
2019-06-30$2.61B$3.47B
2018-06-30$2.34B$3.18B

Bureau of Labor Statistics · retrieved 2026-10-23 · 9 selected series; gaps remain missing

Explore the CPI history ↗